John F. Neylan's Net Worth

$323 Thousand

Estimate Recalculated Jan 2, 2025 04:07PM EST

Who is John F. Neylan?

John F. Neylan does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Angion Biomedica Corp., and KERYX BIOPHARMACEUTICALS INC.

SEC CIK

John F. Neylan's CIK is 0001640447

Past Insider Trading and Trends

2016 was John F. Neylan's most active year for acquiring shares with 2 total transactions. John F. Neylan's most active month to acquire stocks was the month of February. 2018 was John F. Neylan's most active year for disposing of shares, totalling 12 transactions. John F. Neylan's most active month to dispose stocks was the month of March. 2015 saw John F. Neylan paying a total of $62,000.00 for 10,000 shares, this is the most they've acquired in one year. In 2017 John F. Neylan cashed out on 16,305 shares for a total of $91,016.96, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Angion Biomedica Corp. (ELTX) Snapshot price: $3.96

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 2
Form 4
-1.01%
-358.00
$2.62
-$938.00
35.14K
Scheduled
Dec 20
Form 4
-1.04%
-374.00
$4.13
-$1,544.62
35.49K
Scheduled
Nov 18
Form 4
-1.03%
-373.00
$8.62
-$3,215.26
35.87K
Scheduled
Oct 18
Form 4
-1.03%
-376.00
$10.07
-$3,786.32
36.24K
Scheduled
Sep 20
Form 4
-1.03%
-381.00
$9.03
-$3,440.43
36.62K
Scheduled
Aug 18
Form 4
-0.98%
-365.00
$10.98
-$4,007.70
37K
Scheduled
Jul 21
Form 4
-0.97%
-366.00
$13.20
-$4,831.20
37.36K
Scheduled
Jun 18
Form 4
-0.95%
-363.00
$13.91
-$5,049.33
37.73K
Scheduled
May 18
Form 4
-0.99%
-381.00
$13.55
-$5,162.55
38.09K
Scheduled
Apr 19
Form 4
-1.14%
-442.00
$19.13
-$8,455.46
38.45K
Mar 17
Form 4
—
0
—
—
0
Feb 4
Form 3
—
0
—
—
0
No matching records found

KERYX BIOPHARMACEUTICALS INC No price found

Chief Medical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-148.28K
—
—
0
Dec 12
Form 4
-0.77%
-1.16K
$2.77
-$3,202.12
148.28K
Nov 15
Form 4
-0.83%
-1.25K
$3.07
-$3,846.71
149.44K
Oct 29
Form 4
-0.78%
-1.19K
$3.04
-$3,605.44
150.69K
Aug 15
Form 4
-0.84%
-1.28K
$3.86
-$4,948.52
151.87K
Jul 30
Form 4
-0.75%
-1.16K
$5.69
-$6,589.02
153.16K
May 15
Form 4
-0.84%
-1.31K
$4.67
-$6,122.37
154.31K
Apr 30
Form 4
-0.71%
-1.11K
$4.59
-$5,099.49
155.63K
Apr 23
Form 4
+35.72%
41.25K
—
—
156.74K
Mar 20
Form 4
-4.67%
-5.65K
$4.81
-$27,186.12
115.49K
Feb 15
Form 4
-1.26%
-1.54K
$4.81
-$7,412.21
121.14K
Jan 29
Form 4
-1.07%
-1.32K
$4.92
-$6,504.24
122.68K
Jan 23
Form 4
-1.12%
-1.41K
$6.03
-$8,472.15
124K
Oct 30
Form 4
-0.93%
-1.18K
$6.53
-$7,698.87
125.41K
Oct 23
Form 4
-1.13%
-1.45K
$7.14
-$10,317.30
126.58K
Jul 31
Form 4
-0.94%
-1.21K
$7.27
-$8,825.78
128.03K
Jul 24
Form 4
-1.10%
-1.44K
$5.97
-$8,602.77
129.24K
May 1
Form 4
-0.92%
-1.21K
$5.73
-$6,927.57
130.69K
Apr 24
Form 4
+58.63%
48.75K
—
—
131.89K
Feb 14
Form 4
-7.75%
-6.98K
$4.65
-$32,475.60
83.14K
Jan 30
Form 4
-1.56%
-1.43K
$5.39
-$7,696.92
90.13K
Jan 23
Form 4
-1.31%
-1.21K
$4.72
-$5,715.92
91.56K
Oct 24
Form 4
-1.29%
-1.22K
$7.43
-$9,042.31
92.77K
Jul 25
Form 4
-4.83%
-4.77K
$5.21
-$24,830.86
93.98K
Apr 25
Form 4
+119.44%
53.75K
—
—
98.75K
Jan 28
Form 4
+22.22%
10K
$6.20
$62,000.00
55K
Aug 12
Form 3
—
0
—
—
0
No matching records found